The role of Wnt signaling and its interaction with diverse mechanisms of cellular apoptosis in the pathophysiology of bipolar disorder

被引:14
|
作者
Hu, Li Wen [1 ]
Kawamoto, Elisa Mitiko [2 ]
Brietzke, Elisa [1 ]
Scavone, Cristoforo [2 ]
Lafer, Beny [1 ]
机构
[1] Univ Sao Paulo, Dept Psychiat, Sch Med, Bipolar Disorder Res Program, BR-01060970 Sao Paulo, Brazil
[2] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-01060970 Sao Paulo, Brazil
来源
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2011年 / 35卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
Bipolar disorder; GSK3; beta; Inflammation; Neuroplasticity; Wnt; GLYCOGEN-SYNTHASE KINASE-3-BETA; SUBGENUAL PREFRONTAL CORTEX; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; BETA-CATENIN; TRANSDUCTION PATHWAYS; EUTHYMIC PATIENTS; MOOD STABILIZERS; DECREASED LEVELS; GENE-EXPRESSION;
D O I
10.1016/j.pnpbp.2010.08.031
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The neurobiology of Bipolar Disorder (BD) is not completely understood, although abnormalities in neuroplasticity and control of apoptosis have been considered as central events in its pathophysiology. The molecules of the Wnt family comprise a class of proteins that control essential developmental processes such as embryonic patterning, cell growth, migration, and differentiation with their actions largely exerted by modulating gene transcription. The Wnt signaling pathway has interface with some mediators with a well documented action in neuroplasticity and regulation of cell surviving. In addition, mood stabilizers such as lithium and valproate may have their neuroprotective properties in part mediated by the Wnt pathway. This article is an overview of how the Wnt signaling cascade might be involved in the pathogenesis of BD and also in details of intracellular events related to this pathway. Further studies of Wnt signaling may lead to a better comprehension of the neuroprotective actions of mood stabilizers and contribute to improving the therapeutics of BD. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] The role of tumour necrosis factor in the pathophysiology of major depressive disorder, bipolar disorder and schizophrenia
    Gibbons, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 40 - 40
  • [32] Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia
    Altamura, A. Carlo
    Buoli, Massimiliano
    Pozzoli, Sara
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 68 (01) : 21 - 36
  • [33] The Role of Calcium Signaling in Cell Models of Bipolar Disorder
    Williams, Aislinn
    DeLong, Cynthia
    Bame, Monica
    Martinez, Emily
    Lim, Kim-Chew
    Smarsh, Austin
    Doucette, Rylee
    Glanowska, Kasia
    McInnis, Melvin
    Murphy, Geoffrey
    O'Shea, K. Sue
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S186 - S187
  • [34] Wnt5a: Its signaling, cellular functions, and diseases
    Kikuchi, A.
    Yamamoto, H.
    Sato, A.
    Matsumoto, S.
    Hanaki, H.
    DIFFERENTIATION, 2010, 80 : S15 - S15
  • [35] Sphingomyelin and Its Role in Cellular Signaling
    Chakraborty, Mahua
    Jiang, Xian-Cheng
    LIPID-MEDIATED PROTEIN SIGNALING, 2013, 991 : 1 - 14
  • [36] Mechanisms of Disease: role of purinergic signaling in the pathophysiology of bladder dysfunction
    Michael R Ruggieri
    Nature Clinical Practice Urology, 2006, 3 : 206 - 215
  • [37] Mechanisms of Disease: role of purinergic signaling in the pathophysiology of bladder dysfunction
    Ruggieri, MR
    NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (04): : 206 - 215
  • [38] Cellular and molecular actions of lamotrigine: Possible mechanisms of efficacy in bipolar disorder
    Xie, XM
    Hagan, RM
    NEUROPSYCHOBIOLOGY, 1998, 38 (03) : 119 - 130
  • [39] The Wnt signaling pathway and its role in tumor development
    Lustig, B
    Behrens, J
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (04) : 199 - 221
  • [40] The Wnt signaling pathway and its role in tumor development
    B. Lustig
    J. Behrens
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 199 - 221